KRO FY2025 SEC EDGAR DEF 14A #117 of 168 in industry

Kronos Worldwide Inc CEO pay ratio

The CEO earned $2.3M in FY2025 against median worker pay of $98,112 · Chemicals & Pharmaceuticals.

Chemicals & Pharmaceuticals peers All rankings
State
TX
Filing date
2026-03-24
Industry
Chemicals & Pharmaceuticals
Industry rank
#117/168

Data updated August 2026

Subscribe to Kronos Worldwide Inc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
23:1
Below Average (Scale: 0–1000:1)
CEO pay
$2.3M
Median worker
$98,112

Answer first

Kronos Worldwide Inc's FY2025 CEO total of $2.3M ranks #1135 of 1,423 complete filings; its 23:1 pay ratio ranks #1185. Dollar rank is not ratio rank.

According to the same FY2025 complete-filing cohort used on the rankings boards (CEO total, median worker, and ratio all present). Median worker pay is $98,112. Industry placement uses the FY2025 SIC-28 peer cohort (# 117 of 168, 31st percentile - below the industry median pay ratio). Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Dollar rank
#1135
$2.3M of 1,423 FY2025
Ratio rank
#1185
23:1 of 1,423
Industry pct
31st
below the industry median pay ratio

How Kronos Worldwide Inc ranks nationally

Kronos Worldwide Inc CEO pay vs. every FY2025 complete filing

Total CEO compensation, the full national distribution, this company marked

$2,256,576 20th percentile higher than 20% of 1,423 companies

$0–$2,500,000: 304 companies (21%). This entry sits in this band. $2,500,000–$5,000,000: 182 companies (13%). Above this entry. $5,000,000–$7,500,000: 208 companies (15%). Above this entry. $7,500,000–$10,000,000: 192 companies (13%). Above this entry. $10,000,000–$12,500,000: 139 companies (10%). Above this entry. $12,500,000–$15,000,000: 91 companies (6%). Above this entry. $15,000,000–$17,500,000: 88 companies (6%). Above this entry. $17,500,000–$20,000,000: 54 companies (4%). Above this entry. $20,000,000–$22,500,000: 24 companies (2%). Above this entry. $22,500,000–$25,000,000: 34 companies (2%). Above this entry. $25,000,000–$27,500,000: 24 companies (2%). Above this entry. $27,500,000–$30,000,000: 16 companies (1%). Above this entry. $30,000,000–$32,500,000: 10 companies (1%). Above this entry. $32,500,000–$35,000,000: 7 companies (0%). Above this entry. $35,000,000–$37,500,000: 9 companies (1%). Above this entry. $37,500,000–$40,000,000: 6 companies (0%). Above this entry. $40,000,000–$42,500,000: 1 companies (0%). Above this entry. $42,500,000–$45,000,000: 1 companies (0%). Above this entry. $45,000,000–$47,500,000: 6 companies (0%). Above this entry. $47,500,000–$50,000,000: 27 companies (2%). Above this entry. This company $0 $50M+ every complete-filing company, bucketed by value

Each bar is a $2500K-wide band; taller bars hold more companies. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source SEC DEF 14A Section 953(b) disclosures, PlainCEOPay extract · FY2025

Kronos Worldwide Inc vs. Chemicals & Pharmaceuticals peers

CEO total pay ($2.3M) against pay ratio (23:1) for Kronos Worldwide Inc (marked) and its 5 closest same-industry peers, against the Chemicals & Pharmaceuticals industry median on both axes.

Pay + gap both highContained pay, wide gapHigh pay, contained gapBelow peer norms on both1865727.84015392.96165058.08314723.110464388.222.1:127.3:132.5:137.7:143.0:1CEO total payPay ratio (CEO : median worker)Kronos Worldwide Inc, CEO total pay: 2256576 · Pay ratio (CEO : median worker): 23:1Kronos Worldwide IncTravere Therapeutics, Inc., CEO total pay: 8457151 · Pay ratio (CEO : median worker): 23:1Travere Therapeutics, Inc.Schrodinger, Inc., CEO total pay: 4124521 · Pay ratio (CEO : median worker): 23:1Schrodinger, Inc.Nurix Therapeutics, Inc., CEO total pay: 6307796 · Pay ratio (CEO : median worker): 23:1Nurix Therapeutics, Inc.Axsome Therapeutics, Inc., CEO total pay: 10073540 · Pay ratio (CEO : median worker): 23:1Axsome Therapeutics, Inc.Praxis Precision Medicines, Inc., CEO total pay: 8708648 · Pay ratio (CEO : median worker): 23:1Praxis Precision Medicines, Inc.
Kronos Worldwide Inc vs. Chemicals & Pharmaceuticals peers, plotted against the industry's $7.9M median CEO total and 42:1 median pay ratio.

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2025

A component-level pay breakdown is not reported in Kronos Worldwide Inc's structured SEC pay-ratio disclosure. See our methodology →

Filing-year trail · Kronos Worldwide Inc

Complete DEF 14A pay-ratio filings for this CIK across FY2021–2025. Year-over-year deltas compare adjacent filing years only; incomplete dollar rows are omitted (same completeness gate as the hero figures).

Latest ratio
23:1
FY2025
vs prior FY
-2:1
from FY2024 25:1
CEO $ YoY
+0.9%
$2.3M latest
Filings shown
5
FY2021–2025
Kronos Worldwide Inc CEO total compensation, median worker pay, and pay ratio by fiscal year from SEC EDGAR DEF 14A.
FY CEO pay Δ pay Median worker Pay ratio Δ ratio
2021 $3.7M - $93,511 40:1 -
2022 $100K -97% $100,037 18:1 -22:1
2023 $2.2M +2073% $86,955 25:1 +7:1
2024 $2.2M +2.9% $89,469 25:1 0:1
2025 $2.3M +0.9% $98,112 23:1 -2:1

Source: SEC EDGAR DEF 14A pay-ratio disclosures for CIK 1257640, FY2021–2025. Adjacent-year deltas only.

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
23:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$2.3M
Companies in Industry
168
vs. Industry Median
Below
#117 of 168 by pay ratio in this industry View all companies in Chemicals & Pharmaceuticals →

Kronos Worldwide Inc: near-parity Item 402(u) ratio

Kronos Worldwide Inc's FY2025 ratio 23:1 ranks #117 of 168 Chemicals & Pharmaceuticals filers (31st percentile). the CEO earned 23× the median employee ($98,112) in FY2025.

At $98,112 median worker pay, the FLOOR stamp is near pay-parity territory under MID$ CEO total.

CEO Total Pay

$2.3M

FY2025 Summary Compensation, below median

Pay Ratio

23:1

Below typical

Kronos Worldwide Inc in the lower Chemicals & Pharmaceuticals third

Kronos Worldwide Inc's FY2025 ratio 23:1 ranks #117 of 168 Chemicals & Pharmaceuticals filers (31st percentile). The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Kronos Worldwide Inc's $2.3M CEO total is at or below the $7.9M industry median CEO pay.

Dollar rank #1135 and ratio rank #1185 split - treat 23:1 as a disclosure, not a fairness score. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2025

Total Compensation
$2.3M
Median Employee Pay
$98,112
Pay Ratio
23:1
Filing Date
2026-03-24

Company Info

Ticker
KRO
CIK
1257640
Industry
Chemicals & Pharmaceuticals
SIC Code
2810
State
TX
View SEC filings →
SEC EDGAR DEF 14A for CIK 1257640, FY2025. Informational only, not investment advice. Verify on EDGAR.

Read our methodology - how this data is sourced, computed, and verified. Kronos Worldwide Inc's FY2025 ratio 23:1 ranks #117 of 168 Chemicals & Pharmaceuticals filers (31st percentile).

Read with Kronos Worldwide Inc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps FLOOR · MID$ · HIGH-MED.

South Plains Financial, Inc. · MID$

ABS(ceo_total_comp) peer at $2.3M (Δ $11K heavier vs Kronos Worldwide Inc); MODEST · PAR-MED vs this page's FLOOR · MID$ · HIGH-MED.
Nelnet Inc · MID$

ABS(ceo_total_comp) peer at $2.2M (Δ $13K lighter vs Kronos Worldwide Inc); MODEST · PAR-MED vs this page's FLOOR · MID$ · HIGH-MED.
Shenandoah Telecommunications Co/va/ · MID$

ABS(ceo_total_comp) peer at $2.3M (Δ $14K heavier vs Kronos Worldwide Inc); MODEST · HIGH-MED vs this page's FLOOR · MID$ · HIGH-MED.
Leslie's, Inc. · MID$

ABS(ceo_total_comp) peer at $2.2M (Δ $52K lighter vs Kronos Worldwide Inc); MODEST · PAR-MED vs this page's FLOOR · MID$ · HIGH-MED.
Travere Therapeutics, Inc. (SIC 28 pole)

Travere Therapeutics, Inc. stamps FLOOR · HEAVY nearest in-SIC by ABS(pay_ratio) to Kronos Worldwide Inc's FLOOR filing.
National dual ranks · #1135/#1185

Kronos Worldwide Inc's FY2025 package sits #1135 by CEO dollars and #1185 by ratio under MID$ · FLOOR.
Ratio primer · FLOOR

Kronos Worldwide Inc's FLOOR stamp sits in the lower Item 402(u) band - start with how the ratio is disclosed before comparing peers.
Data sourced from SEC EDGAR DEF 14A for Kronos Worldwide Inc (CIK 1257640), FY2025. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.